Dexlansoprazole?

Dexlansoprazole is a proton‑pump inhibitor (PPI) that reduces stomach acid production. It is the “D‑enantiomer” of lansoprazole and is marketed under the brand name Dexilant® (among others).

---

1. What it’s used for

Indication	Typical regimen
Gastroesophageal reflux disease (GERD) – heartburn and esophagitis	15 mg once daily (or 30 mg if needed)
Reflux‑associated disorders (e.g., non‑erosive reflux disease)	15 mg once daily
Erosive esophagitis – healing	30 mg once daily for up to 8 weeks (extendable to 16 weeks in some cases)
Maintenance therapy after healing	15 mg once daily
H. pylori eradication – part of triple or quadruple therapy	30 mg twice daily (with amoxicillin and clarithromycin or metronidazole)

Note: Dexlansoprazole is not typically used for ulcers caused by NSAIDs or for Helicobacter pylori eradication outside of combination regimens; it’s primarily an anti‑acid.

---

2. How it works

• Dexlansoprazole is a prodrug. After absorption, it is converted to the active form that irreversibly inhibits the H⁺/K⁺‑ATPase (the proton pump) in gastric parietal cells.
• It’s a dual‑release formulation: the first 25 % of the dose is released immediately, and the remaining 75 % is released slowly, giving a more prolonged acid suppression compared with some other PPIs.

---

3. Typical dosing

Condition	Dose	Frequency	Notes
GERD (maintenance)	15 mg	once daily	Can increase to 30 mg if symptoms persist
GERD (acute)	30 mg	once daily	8‑16 weeks may be required
Erosive esophagitis	30 mg	once daily	8–16 weeks; extend only if clinically indicated
H. pylori (triple therapy)	30 mg	twice daily	Taken with amoxicillin + clarithromycin or metronidazole

• Take orally with a full glass of water.
• Take before a meal (30‑60 min before breakfast is typical).
• Do not crush or chew the tablet; swallowing whole ensures proper release.

---

4. Common side effects

• Headache
• Abdominal pain / flatulence
• Nausea
• Diarrhea or constipation
• Rarely: rash or itching

Serious but uncommon: Clostridioides difficile infection, vitamin B12 deficiency (long‑term use), hypomagnesemia, osteoporotic fractures (especially with >1 year of therapy), and possible increased risk of pneumonia or community‑acquired infections.

---

5. Drug interactions

Drug	Interaction	Clinical implication
Clopidogrel	PPI can reduce clopidogrel’s conversion to its active metabolite.	Consider using a different PPI or an alternative antiplatelet if high risk of cardiovascular events.
Warfarin	Minimal interaction, but monitor INR if you’re on warfarin.
Diazepam / Lorazepam	Slight reduction in bioavailability; usually not clinically significant.
Ketoconazole	PPI can increase ketoconazole absorption; monitor for toxicity.
Cimetidine	No major effect.
St. John’s wort	Can reduce effectiveness of PPIs.
Immunosuppressants (e.g., tacrolimus)	PPIs may increase trough levels; monitor drug levels.

Always inform your healthcare provider about all medications you’re taking, including over‑the‑counter drugs and supplements.

---

6. Warnings & precautions

• Long‑term use (>12 months) should be re‑evaluated to minimize unnecessary exposure.
• Kidney disease: Dexlansoprazole is primarily hepatic, so renal impairment isn’t a major concern, but monitor renal function if you have significant kidney disease.
• Pregnancy & lactation: Not enough data; generally considered safe but discuss risks vs. benefits with your provider.
• History of GI bleeding or ulcers: Use caution; consider H₂ blockers if a PPI is not absolutely needed.

---

7. How to take it

1. Timing: Take 30–60 minutes before your first meal of the day.
2. Position: Sit upright or stand while swallowing; avoid lying down immediately afterward.
3. Consistency: Take it at the same time each day for best effect.

---

8. When to seek help

• Persistent heartburn or reflux after 8 weeks of therapy.
• New or worsening abdominal pain, vomiting, or black/tarry stools (possible GI bleeding).
• Signs of infection (fever, chills) that could indicate C. difficile or pneumonia.
• Symptoms of hypomagnesemia (muscle cramps, arrhythmias) or vitamin B12 deficiency (fatigue, numbness).

---

9. Bottom line

Dexlansoprazole is an effective, dual‑release PPI for GERD, erosive esophagitis, and as part of H. pylori eradication regimens. Its prolonged acid suppression can improve symptom relief and healing, but like all PPIs it carries a risk of side effects and drug interactions—especially with antiplatelet agents and immunosuppressants.

Always discuss your full medication list and medical history with your prescribing clinician to make sure dexlansoprazole is the right choice for you.